The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 23, pp. 2426 - 2437
In nine patients with neonatal onset of severe inflammatory lesions affecting mainly bone and skin and associated with mutations of IL1RN, which encodes the...
CELLS | MEDICINE, GENERAL & INTERNAL | GENE-CLUSTER | INFLAMMASOME | MUTATIONS | CIAS1 | SECRETION | ARTHRITIS | ASSOCIATION | INFANTILE CORTICAL HYPEROSTOSIS | FAMILY | Interleukin-1 - genetics | Humans | Infant | Interleukin 1 Receptor Antagonist Protein - genetics | Male | RNA, Messenger - metabolism | Autoimmune Diseases - genetics | Inflammation - drug therapy | Base Sequence | Interleukin-1 - physiology | Female | Child | Autoimmune Diseases - drug therapy | Infant, Newborn | Interleukin 1 Receptor Antagonist Protein - deficiency | Interleukin-1beta - antagonists & inhibitors | Inflammation - immunology | Genes, Recessive | Homozygote | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pedigree | Inflammation - genetics | Mutation | Receptors, Interleukin-1 - antagonists & inhibitors | Interleukin-1 | Usage | Gene mutations | Causes of | Research | Autoimmune diseases | Drug therapy | Health aspects | Proteins | Genetics | Skin | Genetic testing | Clinical Medicine | Pediatrics | Medical and Health Sciences | Hematologi | Hematology | Medicin och hälsovetenskap | Pediatrik | Klinisk medicin
CELLS | MEDICINE, GENERAL & INTERNAL | GENE-CLUSTER | INFLAMMASOME | MUTATIONS | CIAS1 | SECRETION | ARTHRITIS | ASSOCIATION | INFANTILE CORTICAL HYPEROSTOSIS | FAMILY | Interleukin-1 - genetics | Humans | Infant | Interleukin 1 Receptor Antagonist Protein - genetics | Male | RNA, Messenger - metabolism | Autoimmune Diseases - genetics | Inflammation - drug therapy | Base Sequence | Interleukin-1 - physiology | Female | Child | Autoimmune Diseases - drug therapy | Infant, Newborn | Interleukin 1 Receptor Antagonist Protein - deficiency | Interleukin-1beta - antagonists & inhibitors | Inflammation - immunology | Genes, Recessive | Homozygote | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pedigree | Inflammation - genetics | Mutation | Receptors, Interleukin-1 - antagonists & inhibitors | Interleukin-1 | Usage | Gene mutations | Causes of | Research | Autoimmune diseases | Drug therapy | Health aspects | Proteins | Genetics | Skin | Genetic testing | Clinical Medicine | Pediatrics | Medical and Health Sciences | Hematologi | Hematology | Medicin och hälsovetenskap | Pediatrik | Klinisk medicin
Journal Article
Leukemia, ISSN 0887-6924, 05/2018, Volume 32, Issue 5, pp. 1106 - 1115
Germline mutations in the SAMD9 and SAMD9L genes, located in tandem on chromosome 7, are associated with a clinical spectrum of disorders including the MIRAGE...
C-MONOSOMY | HEMATOPOIESIS | ONCOLOGY | CEREBELLAR-ATAXIA | DISORDER | CHROMOSOME-7 | HYPOPLASTIC-ANEMIA | LEUKEMIA | HEMATOLOGY | MYELODYSPLASTIC SYNDROME | FANCONI-ANEMIA | SOMATIC MUTATIONS | Proteins - genetics | Genetic Predisposition to Disease | Humans | Tumor Suppressor Proteins - genetics | Germ-Line Mutation | Heterozygote | Myelodysplastic Syndromes - genetics | Ataxia - genetics | Pancytopenia - genetics | Leukemia, Myeloid, Acute - genetics | Care and treatment | Genetic aspects | Research | Gene mutations | Chromosomes | Myelodysplastic syndromes | Cerebellum | Adrenal glands | Leukemia | Glands | Myelodysplasia | Hemorrhage | Myelodysplastic syndrome | Thymus | Atrophy | Ataxia | Children | Monosomy | Hypoplasia | Phenotypes | Hematology | Anemia | Blood cells | Chromosome 7 | Ovaries | Patients | Hemopoiesis | Carriers | Pancytopenia | Nystagmus | Mutation | Testes | Cancer genetics | Genetics research | Review | Basic Medicine | Medical Genetics | Medicinsk genetik | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
C-MONOSOMY | HEMATOPOIESIS | ONCOLOGY | CEREBELLAR-ATAXIA | DISORDER | CHROMOSOME-7 | HYPOPLASTIC-ANEMIA | LEUKEMIA | HEMATOLOGY | MYELODYSPLASTIC SYNDROME | FANCONI-ANEMIA | SOMATIC MUTATIONS | Proteins - genetics | Genetic Predisposition to Disease | Humans | Tumor Suppressor Proteins - genetics | Germ-Line Mutation | Heterozygote | Myelodysplastic Syndromes - genetics | Ataxia - genetics | Pancytopenia - genetics | Leukemia, Myeloid, Acute - genetics | Care and treatment | Genetic aspects | Research | Gene mutations | Chromosomes | Myelodysplastic syndromes | Cerebellum | Adrenal glands | Leukemia | Glands | Myelodysplasia | Hemorrhage | Myelodysplastic syndrome | Thymus | Atrophy | Ataxia | Children | Monosomy | Hypoplasia | Phenotypes | Hematology | Anemia | Blood cells | Chromosome 7 | Ovaries | Patients | Hemopoiesis | Carriers | Pancytopenia | Nystagmus | Mutation | Testes | Cancer genetics | Genetics research | Review | Basic Medicine | Medical Genetics | Medicinsk genetik | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 16, pp. 2266 - 2279
Several monogenic causes of familial myelodysplastic syndrome (MDS) have recently been identified. We studied 2 families with cytopenia, predisposition to MDS...
FAMILIAL TUMORAL CALCINOSIS | GERM-LINE | FANCONI-ANEMIA REGISTRY | HEMATOPOIETIC STEM-CELLS | IN-VIVO | SPONTANEOUS REMISSION | ACUTE MYELOID-LEUKEMIA | RETROSPECTIVE ANALYSIS | HEMATOLOGY | DETECTABLE CLONAL MOSAICISM | MYELODYSPLASTIC SYNDROMES | Cell Proliferation | Humans | Middle Aged | Pancytopenia - immunology | Male | Killer Cells, Natural - pathology | Cognitive Dysfunction - immunology | Interferon Type I - pharmacology | Myeloid Cells - immunology | Tumor Suppressor Proteins - genetics | Killer Cells, Natural - immunology | Adult | Cognitive Dysfunction - genetics | Female | Myeloid Cells - drug effects | Cognitive Dysfunction - diagnosis | B-Lymphocytes - pathology | Cognitive Dysfunction - complications | Immunologic Deficiency Syndromes - diagnosis | Immunologic Deficiency Syndromes - immunology | Child | Gene Expression | Tumor Suppressor Proteins - metabolism | Immunologic Deficiency Syndromes - complications | Pancytopenia - diagnosis | Immunophenotyping | Myelodysplastic Syndromes - complications | B-Lymphocytes - drug effects | Hematopoiesis - immunology | Myelodysplastic Syndromes - diagnosis | B-Lymphocytes - immunology | Pancytopenia - complications | Pedigree | Alleles | Immunologic Deficiency Syndromes - genetics | Heterozygote | Mosaicism | Killer Cells, Natural - drug effects | Myelodysplastic Syndromes - genetics | Mutation | Myeloid Cells - pathology | Chromosomes, Human, Pair 7 - chemistry | Pancytopenia - genetics | Myelodysplastic Syndromes - immunology | Myeloid Neoplasia | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Klinisk medicin | Medicin och hälsovetenskap
FAMILIAL TUMORAL CALCINOSIS | GERM-LINE | FANCONI-ANEMIA REGISTRY | HEMATOPOIETIC STEM-CELLS | IN-VIVO | SPONTANEOUS REMISSION | ACUTE MYELOID-LEUKEMIA | RETROSPECTIVE ANALYSIS | HEMATOLOGY | DETECTABLE CLONAL MOSAICISM | MYELODYSPLASTIC SYNDROMES | Cell Proliferation | Humans | Middle Aged | Pancytopenia - immunology | Male | Killer Cells, Natural - pathology | Cognitive Dysfunction - immunology | Interferon Type I - pharmacology | Myeloid Cells - immunology | Tumor Suppressor Proteins - genetics | Killer Cells, Natural - immunology | Adult | Cognitive Dysfunction - genetics | Female | Myeloid Cells - drug effects | Cognitive Dysfunction - diagnosis | B-Lymphocytes - pathology | Cognitive Dysfunction - complications | Immunologic Deficiency Syndromes - diagnosis | Immunologic Deficiency Syndromes - immunology | Child | Gene Expression | Tumor Suppressor Proteins - metabolism | Immunologic Deficiency Syndromes - complications | Pancytopenia - diagnosis | Immunophenotyping | Myelodysplastic Syndromes - complications | B-Lymphocytes - drug effects | Hematopoiesis - immunology | Myelodysplastic Syndromes - diagnosis | B-Lymphocytes - immunology | Pancytopenia - complications | Pedigree | Alleles | Immunologic Deficiency Syndromes - genetics | Heterozygote | Mosaicism | Killer Cells, Natural - drug effects | Myelodysplastic Syndromes - genetics | Mutation | Myeloid Cells - pathology | Chromosomes, Human, Pair 7 - chemistry | Pancytopenia - genetics | Myelodysplastic Syndromes - immunology | Myeloid Neoplasia | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Blood, ISSN 0006-4971, 05/2018, Volume 131, Issue 22, pp. 2475 - 2484
Thromboembolism frequently occurs during acute lymphoblastic leukemia (ALL) therapy. We prospectively registered thromboembolic events during the treatment of...
L-ASPARAGINASE | ADULT PATIENTS | THROMBOTIC COMPLICATIONS | RISK-FACTORS | VENOUS THROMBOEMBOLISM | INDUCTION THERAPY | ANTITHROMBIN | COAGULATION | HEMATOLOGY | CHEMOTHERAPY | CHILDREN | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Age Factors | Thromboembolism - chemically induced | Humans | Middle Aged | Risk Factors | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Incidence | Young Adult | Asparaginase - adverse effects | Thromboembolism - prevention & control | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Adult | Female | Asparaginase - therapeutic use | Child | Lymphoid Neoplasia | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Klinisk medicin | Medicin och hälsovetenskap
L-ASPARAGINASE | ADULT PATIENTS | THROMBOTIC COMPLICATIONS | RISK-FACTORS | VENOUS THROMBOEMBOLISM | INDUCTION THERAPY | ANTITHROMBIN | COAGULATION | HEMATOLOGY | CHEMOTHERAPY | CHILDREN | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Age Factors | Thromboembolism - chemically induced | Humans | Middle Aged | Risk Factors | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Incidence | Young Adult | Asparaginase - adverse effects | Thromboembolism - prevention & control | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Adult | Female | Asparaginase - therapeutic use | Child | Lymphoid Neoplasia | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2016, Volume 175, Issue 2, pp. 318 - 330
Summary Accurate diagnosis of rare inherited anaemias is challenging, requiring a series of complex and expensive laboratory tests. Targeted...
molecular genetics | inherited anaemia | congenital dyserythropoietic anaemia | pyruvate kinase deficiency | next‐generation sequencing | VARIANTS | next-generation sequencing | STANDARDS | DEFICIENCY | PRECISION | HEMOLYTIC-ANEMIA | DIAMOND-BLACKFAN ANEMIA | MUTATIONS | HEMATOLOGY | WHOLE GENOME | BONE-MARROW FAILURE | REVEALS | Computational Biology - methods | Genetic Predisposition to Disease | Reproducibility of Results | Genetic Association Studies | Genetic Testing - standards | Humans | Anemia - diagnosis | Infant | Male | Workflow | Rare Diseases | Genetic Testing - methods | Anemia - genetics | Disease Management | High-Throughput Nucleotide Sequencing | Polymorphism, Single Nucleotide | Mutation | Genetic disorders | Diagnostic equipment (Medical) | Molecular genetics | Anemia | Genes | Diagnosis | Nucleotide sequencing | DNA sequencing | Red Cells and Iron | Research Paper | Clinical Medicine | Congenital dyserythropoietic anaemia | Next-generation sequencing | Inherited anaemia | Hematologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Pyruvate kinase deficiency | Klinisk medicin
molecular genetics | inherited anaemia | congenital dyserythropoietic anaemia | pyruvate kinase deficiency | next‐generation sequencing | VARIANTS | next-generation sequencing | STANDARDS | DEFICIENCY | PRECISION | HEMOLYTIC-ANEMIA | DIAMOND-BLACKFAN ANEMIA | MUTATIONS | HEMATOLOGY | WHOLE GENOME | BONE-MARROW FAILURE | REVEALS | Computational Biology - methods | Genetic Predisposition to Disease | Reproducibility of Results | Genetic Association Studies | Genetic Testing - standards | Humans | Anemia - diagnosis | Infant | Male | Workflow | Rare Diseases | Genetic Testing - methods | Anemia - genetics | Disease Management | High-Throughput Nucleotide Sequencing | Polymorphism, Single Nucleotide | Mutation | Genetic disorders | Diagnostic equipment (Medical) | Molecular genetics | Anemia | Genes | Diagnosis | Nucleotide sequencing | DNA sequencing | Red Cells and Iron | Research Paper | Clinical Medicine | Congenital dyserythropoietic anaemia | Next-generation sequencing | Inherited anaemia | Hematologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Pyruvate kinase deficiency | Klinisk medicin
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2015, Volume 168, Issue 4, pp. 547 - 552
Summary We present a prospective multicentre cohort of 20 children with acute lymphoblastic leukaemia (ALL) and cerebral sinus venous thrombosis (CSVT). The...
cerebral sinovenous thrombosis | acute leukaemia | paediatric | ASPARAGINASE | METAANALYSIS | SINOVENOUS THROMBOSIS | PROTOCOL | RISK | HEMATOLOGY | ISCHEMIC-STROKE | CANCER | Baltic States - epidemiology | Prospective Studies | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Consolidation Chemotherapy | Sinus Thrombosis, Intracranial - epidemiology | Incidence | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Asparaginase - adverse effects | Female | Child | Scandinavian and Nordic Countries - epidemiology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Risk Factors | Sinus Thrombosis, Intracranial - etiology | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Asparaginase - administration & dosage | Adrenal Cortex Hormones - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Sinus Thrombosis, Intracranial - drug therapy | Paediatric | Acute leukaemia | Cerebral sinovenous thrombosis | Pediatrics | Trade and professional associations | Children | Clinical Medicine | Hematologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Klinisk medicin
cerebral sinovenous thrombosis | acute leukaemia | paediatric | ASPARAGINASE | METAANALYSIS | SINOVENOUS THROMBOSIS | PROTOCOL | RISK | HEMATOLOGY | ISCHEMIC-STROKE | CANCER | Baltic States - epidemiology | Prospective Studies | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Consolidation Chemotherapy | Sinus Thrombosis, Intracranial - epidemiology | Incidence | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Asparaginase - adverse effects | Female | Child | Scandinavian and Nordic Countries - epidemiology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Risk Factors | Sinus Thrombosis, Intracranial - etiology | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Asparaginase - administration & dosage | Adrenal Cortex Hormones - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Sinus Thrombosis, Intracranial - drug therapy | Paediatric | Acute leukaemia | Cerebral sinovenous thrombosis | Pediatrics | Trade and professional associations | Children | Clinical Medicine | Hematologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
European Journal of Pediatrics, ISSN 0340-6199, 9/2012, Volume 171, Issue 9, pp. 1383 - 1387
We describe two children with significant bleeding: one with multiple ecchymoses and the other with scrotal bleeding. In both patients, the activated partial...
Pediatrics | Lupus anticoagulants | Medicine & Public Health | Coagulation | Antiprothrombin antibodies | Children | Bleeding | MECHANISM | THROMBOSIS | IDIOPATHIC CEREBRAL-ISCHEMIA | IGG | PREVALENCE | ANTIPHOSPHOLIPID SYNDROME | ACQUIRED HYPOPROTHROMBINEMIA | PEDIATRICS | INHIBITORS | ANTI-PROTHROMBIN ANTIBODIES | Lupus Coagulation Inhibitor - blood | Humans | Prothrombin Time | Child, Preschool | Male | Biomarkers - blood | Blood Coagulation Disorders - virology | Partial Thromboplastin Time | Adenoviridae Infections - complications | Blood Coagulation Disorders - blood | Female | Hemorrhagic Disorders - etiology | Blood Coagulation Disorders - diagnosis | Prothrombin - metabolism | Child | Blood Coagulation Disorders - complications | Lupus | Viral antibodies | Medical examination | Prothrombin | Antibodies | Thrombin | Anticoagulants (Medicine) | Blood | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Pediatrik | Klinisk medicin
Pediatrics | Lupus anticoagulants | Medicine & Public Health | Coagulation | Antiprothrombin antibodies | Children | Bleeding | MECHANISM | THROMBOSIS | IDIOPATHIC CEREBRAL-ISCHEMIA | IGG | PREVALENCE | ANTIPHOSPHOLIPID SYNDROME | ACQUIRED HYPOPROTHROMBINEMIA | PEDIATRICS | INHIBITORS | ANTI-PROTHROMBIN ANTIBODIES | Lupus Coagulation Inhibitor - blood | Humans | Prothrombin Time | Child, Preschool | Male | Biomarkers - blood | Blood Coagulation Disorders - virology | Partial Thromboplastin Time | Adenoviridae Infections - complications | Blood Coagulation Disorders - blood | Female | Hemorrhagic Disorders - etiology | Blood Coagulation Disorders - diagnosis | Prothrombin - metabolism | Child | Blood Coagulation Disorders - complications | Lupus | Viral antibodies | Medical examination | Prothrombin | Antibodies | Thrombin | Anticoagulants (Medicine) | Blood | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Pediatrik | Klinisk medicin
Journal Article
Acta Paediatrica, ISSN 0803-5253, 01/2018, Volume 107, Issue 1, pp. 166 - 167
Journal Article
Nordic Journal of Psychiatry, ISSN 0803-9488, 09/2019
Background: An infant’s development is closely linked to the relationship they have with their parents. Parenting stress, affective disorder, and an upbringing...
parenting stress | Clinical Medicine | Pediatrics | gender | Medical and Health Sciences | Medicin och hälsovetenskap | Pediatrik | Infant mental health | Psykiatri | postnatal affective disorder | Klinisk medicin | Psychiatry
parenting stress | Clinical Medicine | Pediatrics | gender | Medical and Health Sciences | Medicin och hälsovetenskap | Pediatrik | Infant mental health | Psykiatri | postnatal affective disorder | Klinisk medicin | Psychiatry
Journal Article
Acta Paediatrica, ISSN 0803-5253, 09/2016, Volume 105, Issue 9, pp. 1088 - 1093
Aim This study aimed to evaluate the concomitant occurrence and possible association of breath‐holding spells (BHS) and transient erythroblastopenia of...
Breath‐holding spells | Paediatric | Transient erythroblastopenia of childhood | Anaemia | Breath-holding spells | ERYTHROPOIESIS | SIBLINGS | PEDIATRICS | CHILDHOOD | Humans | Anemia, Hemolytic, Congenital - blood | Breath Holding | Female | Infant | Male | Anemia, Hemolytic, Congenital - physiopathology | Retrospective Studies | Anemia | Analysis | Children | Health risk assessment | Clinical Medicine | Pediatrics | Hematologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Pediatrik | Klinisk medicin
Breath‐holding spells | Paediatric | Transient erythroblastopenia of childhood | Anaemia | Breath-holding spells | ERYTHROPOIESIS | SIBLINGS | PEDIATRICS | CHILDHOOD | Humans | Anemia, Hemolytic, Congenital - blood | Breath Holding | Female | Infant | Male | Anemia, Hemolytic, Congenital - physiopathology | Retrospective Studies | Anemia | Analysis | Children | Health risk assessment | Clinical Medicine | Pediatrics | Hematologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Pediatrik | Klinisk medicin
Journal Article
European Journal of Haematology, ISSN 0902-4441, 02/2015, Volume 94, Issue 77, pp. 11 - 16
Haemophilia prophylaxis is superior to on‐demand treatment to prevent joint damage. ‘High‐dose prophylaxis’ as used in Sweden is more effective in preventing...
haemophilia | treatment | inhibitors | children | prophylaxis | Haemophilia | Inhibitors | Treatment | Children | Prophylaxis | CANADIAN HEMOPHILIA | MRI SCALE | ARTHROPATHY | FOLLOW-UP | TAILORED PROPHYLAXIS | JOINT HEALTH SCORE | ON-DEMAND | INHIBITOR DEVELOPMENT | QUALITY-OF-LIFE | FACTOR VIII | HEMATOLOGY | Factor VIII - immunology | Joints - blood supply | Hemophilia A - diagnostic imaging | Age Factors | Humans | Child, Preschool | Infant | Factor VIII - antagonists & inhibitors | Ultrasonography | Arthritis - immunology | Adult | Arthritis - prevention & control | Factor VIII - therapeutic use | Drug Administration Schedule | Arthritis - pathology | Joints - drug effects | Arthritis - diagnostic imaging | Hemophilia A - immunology | Risk Factors | Catheterization, Central Venous | Joints - pathology | Hemophilia A - pathology | Magnetic Resonance Imaging | Joints - immunology | Hemarthrosis - immunology | Hemarthrosis - diagnostic imaging | Quality of Life | Antibodies - blood | Hemarthrosis - pathology | Hemarthrosis - prevention & control | Hemophilia A - drug therapy | Drug therapy | Medicine, Preventive | Hemophilia | Preventive health services | Clinical Medicine | Hematologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Klinisk medicin
haemophilia | treatment | inhibitors | children | prophylaxis | Haemophilia | Inhibitors | Treatment | Children | Prophylaxis | CANADIAN HEMOPHILIA | MRI SCALE | ARTHROPATHY | FOLLOW-UP | TAILORED PROPHYLAXIS | JOINT HEALTH SCORE | ON-DEMAND | INHIBITOR DEVELOPMENT | QUALITY-OF-LIFE | FACTOR VIII | HEMATOLOGY | Factor VIII - immunology | Joints - blood supply | Hemophilia A - diagnostic imaging | Age Factors | Humans | Child, Preschool | Infant | Factor VIII - antagonists & inhibitors | Ultrasonography | Arthritis - immunology | Adult | Arthritis - prevention & control | Factor VIII - therapeutic use | Drug Administration Schedule | Arthritis - pathology | Joints - drug effects | Arthritis - diagnostic imaging | Hemophilia A - immunology | Risk Factors | Catheterization, Central Venous | Joints - pathology | Hemophilia A - pathology | Magnetic Resonance Imaging | Joints - immunology | Hemarthrosis - immunology | Hemarthrosis - diagnostic imaging | Quality of Life | Antibodies - blood | Hemarthrosis - pathology | Hemarthrosis - prevention & control | Hemophilia A - drug therapy | Drug therapy | Medicine, Preventive | Hemophilia | Preventive health services | Clinical Medicine | Hematologi | Medical and Health Sciences | Hematology | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
Acta Paediatrica, ISSN 0803-5253, 07/2012, Volume 101, Issue 7, pp. 761 - 766
Aim: To describe the clinical course, morbidity and platelet recovery in an unselected Nordic cohort of children with chronic Immune Thrombocytopenic Purpura...
Thrombocytopenia | Platelets | Chronic ITP | MANAGEMENT | SPONTANEOUS-RECOVERY | CHILDHOOD-ITP | IDIOPATHIC THROMBOCYTOPENIA | ADULTS | PEDIATRICS | SPLENECTOMY | ITP-STUDY-GROUP | INTRACRANIAL HEMORRHAGE | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Child, Preschool | Hospitalization - statistics & numerical data | Infant | Male | Recovery of Function | Purpura, Thrombocytopenic, Idiopathic - blood | Splenectomy | Purpura, Thrombocytopenic, Idiopathic - therapy | Time Factors | Female | Purpura, Thrombocytopenic, Idiopathic - epidemiology | Child | Infant, Newborn | Scandinavian and Nordic Countries - epidemiology | Severity of Illness Index | Kaplan-Meier Estimate | Platelet Count | Adolescent | Remission, Spontaneous | Chronic Disease | Finland - epidemiology | Clinical Medicine | Pediatrics | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Pediatrik
Thrombocytopenia | Platelets | Chronic ITP | MANAGEMENT | SPONTANEOUS-RECOVERY | CHILDHOOD-ITP | IDIOPATHIC THROMBOCYTOPENIA | ADULTS | PEDIATRICS | SPLENECTOMY | ITP-STUDY-GROUP | INTRACRANIAL HEMORRHAGE | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Child, Preschool | Hospitalization - statistics & numerical data | Infant | Male | Recovery of Function | Purpura, Thrombocytopenic, Idiopathic - blood | Splenectomy | Purpura, Thrombocytopenic, Idiopathic - therapy | Time Factors | Female | Purpura, Thrombocytopenic, Idiopathic - epidemiology | Child | Infant, Newborn | Scandinavian and Nordic Countries - epidemiology | Severity of Illness Index | Kaplan-Meier Estimate | Platelet Count | Adolescent | Remission, Spontaneous | Chronic Disease | Finland - epidemiology | Clinical Medicine | Pediatrics | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Pediatrik
Journal Article
Leukemia, ISSN 0887-6924, 05/2018, Volume 32, Issue 5, p. 1106
Germline mutations in the SAMD9 and SAMD9L genes, located in tandem on chromosome 7, are associated with a clinical spectrum of disorders including the MIRAGE...
Basic Medicine | SAMD9L | Neurosciences | SAMD9 | Medical and Health Sciences | Medicin och hälsovetenskap | myeloid malignancies | Klinisk medicin | Clinical Medicine | Medicinska och farmaceutiska grundvetenskaper | Ataxia | Cancer and Oncology | Neurovetenskaper | Cancer och onkologi
Basic Medicine | SAMD9L | Neurosciences | SAMD9 | Medical and Health Sciences | Medicin och hälsovetenskap | myeloid malignancies | Klinisk medicin | Clinical Medicine | Medicinska och farmaceutiska grundvetenskaper | Ataxia | Cancer and Oncology | Neurovetenskaper | Cancer och onkologi
Journal Article
Nordic Journal of Psychiatry, ISSN 0803-9488, 09/2019, pp. 1 - 10
Background: An infant's development is closely linked to the relationship they have with their parents. Parenting stress, affective disorder, and an upbringing...
parenting stress | Neurosciences | adversity | gender | childhood | maltreatment history | hospital anxiety | postnatal affective disorder | psychological distress | depressive symptoms | alcohol-use disorders | gender-differences | Infant mental health | postpartum | depression | Psychiatry | maternal depression | Neurovetenskaper | intergenerational transmission
parenting stress | Neurosciences | adversity | gender | childhood | maltreatment history | hospital anxiety | postnatal affective disorder | psychological distress | depressive symptoms | alcohol-use disorders | gender-differences | Infant mental health | postpartum | depression | Psychiatry | maternal depression | Neurovetenskaper | intergenerational transmission
Journal Article